SCHEMBL19234267

SCHEMBL19234267

CNC(=O)n1cc(OC#N)c2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ POLB P06746 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ THRB P10828 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ EGFR P00533 1/20 0.36
▸ PLK1 P53350 1/20 0.36
▸ CREBBP Q92793 1/20 0.36
▸ PTPN7 P35236 1/20 0.36
▸ NR4A2 P43354 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19233806 0.84 CREBBP (0.47) KMT2AMEN1POLBKDM4EALDH1A1
SCHEMBL19234263 0.81 KMT2A (0.36) KMT2AMEN1POLBKDM4EALDH1A1
SCHEMBL8528867 0.74 KMT2A (0.43) KMT2AMEN1POLBKDM4EALDH1A1
SCHEMBL8528870 0.74 TFPI2 (0.47) KMT2AMEN1POLBKDM4EALDH1A1
SCHEMBL12479933 0.72 KMT2A (0.51) KMT2AMEN1POLBKDM4EALDH1A1
SCHEMBL13967298 0.71 KMT2A (0.40) KMT2AMEN1POLBKDM4EALDH1A1
SCHEMBL12481080 0.70 KMT2A (0.38) KMT2AMEN1POLBKDM4EALDH1A1
SCHEMBL25827703 0.69 IMPDH2 (0.36) KMT2AMEN1POLBALDH1A1LMNA
SCHEMBL10842053 0.67 KMT2A (0.65) KMT2AMEN1POLBKDM4EALDH1A1
SCHEMBL9848044 0.67 KMT2A (0.46) KMT2AMEN1POLBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2661433-B1 INDOLE COMPOUNDS OR ANALOGUES THEREOF USEFUL FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD) NOVARTIS AG (CH) 2017-08-16 — — EP disclosed
Send feedback